By Colin KellaherShares of Aura Biosciences Inc. edged higher in their trading debut Friday after the clinical-stage oncology company's upsized initial public offering was priced at the low end of views. Aura shares were recently trading at $14.25, up about 1.8%, after opening at $14.10.

Source: Wall Street Journal October 29, 2021 18:52 UTC